Published in Prim Care Companion CNS Disord on March 13, 2014
The role of maternal obesity in the risk of neuropsychiatric disorders. Front Neurosci (2015) 0.85
Maternal Obesity and Neurodevelopmental and Psychiatric Disorders in Offspring. Prenat Diagn (2016) 0.76
Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet (2007) 11.27
A systematic review of the prevalence of schizophrenia. PLoS Med (2005) 6.99
Persistent cannabis users show neuropsychological decline from childhood to midlife. Proc Natl Acad Sci U S A (2012) 5.67
A systematic review and meta-analysis of the psychosis continuum: evidence for a psychosis proneness-persistence-impairment model of psychotic disorder. Psychol Med (2008) 5.61
Incidental findings on brain magnetic resonance imaging from 1000 asymptomatic volunteers. JAMA (1999) 5.61
Association between duration of untreated psychosis and outcome in cohorts of first-episode patients: a systematic review. Arch Gen Psychiatry (2005) 5.57
Cognitive therapy for the prevention of psychosis in people at ultra-high risk: randomised controlled trial. Br J Psychiatry (2004) 4.74
Children's self-reported psychotic symptoms and adult schizophreniform disorder: a 15-year longitudinal study. Arch Gen Psychiatry (2000) 4.35
Randomized, double-blind trial of olanzapine versus placebo in patients prodromally symptomatic for psychosis. Am J Psychiatry (2006) 4.18
Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms. Arch Gen Psychiatry (2002) 4.06
Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial. Arch Gen Psychiatry (2010) 3.82
The neurodevelopmental model of schizophrenia: update 2005. Mol Psychiatry (2005) 3.68
Brain volume in first-episode schizophrenia: systematic review and meta-analysis of magnetic resonance imaging studies. Br J Psychiatry (2006) 3.66
Effectiveness of a brief cognitive-behavioural therapy intervention in the treatment of schizophrenia. Br J Psychiatry (2002) 3.44
Double-blind comparison of first- and second-generation antipsychotics in early-onset schizophrenia and schizo-affective disorder: findings from the treatment of early-onset schizophrenia spectrum disorders (TEOSS) study. Am J Psychiatry (2008) 3.30
Early intervention for psychosis. Cochrane Database Syst Rev (2011) 3.04
Cannabis use and the risk of later schizophrenia: a review. Addiction (2004) 2.98
Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET. Nature (1997) 2.46
Long-acting injectable risperidone: efficacy and safety of the first long-acting atypical antipsychotic. Am J Psychiatry (2003) 2.24
Excessive brain volume loss over time in cannabis-using first-episode schizophrenia patients. Am J Psychiatry (2008) 2.20
Cognitive remediation improves memory and psychosocial functioning in first-episode psychiatric out-patients. Psychol Med (2012) 2.07
Childhood-onset schizophrenia. A double-blind clozapine-haloperidol comparison. Arch Gen Psychiatry (1996) 1.92
A multiple-center, randomized, double-blind, placebo-controlled study of oral aripiprazole for treatment of adolescents with schizophrenia. Am J Psychiatry (2008) 1.89
Progressive cortical change during adolescence in childhood-onset schizophrenia. A longitudinal magnetic resonance imaging study. Arch Gen Psychiatry (1999) 1.78
Predictors of noncompliance in patients with schizophrenia. J Clin Psychiatry (2002) 1.76
Psychotic symptoms and population risk for suicide attempt: a prospective cohort study. JAMA Psychiatry (2013) 1.69
IQ and non-clinical psychotic symptoms in 12-year-olds: results from the ALSPAC birth cohort. Br J Psychiatry (2008) 1.64
Efficacy, safety and tolerability of two dosing regimens in adolescent schizophrenia: double-blind study. Br J Psychiatry (2009) 1.61
Metabolic and endocrine adverse effects of second-generation antipsychotics in children and adolescents: A systematic review of randomized, placebo controlled trials and guidelines for clinical practice. Eur Psychiatry (2011) 1.58
Schizophrenia and schizophrenia-spectrum personality disorders in the first-degree relatives of children with schizophrenia: the UCLA family study. Arch Gen Psychiatry (2001) 1.57
Are screening instruments valid for psychotic-like experiences? A validation study of screening questions for psychotic-like experiences using in-depth clinical interview. Schizophr Bull (2009) 1.49
Community screening for psychotic-like experiences and other putative antecedents of schizophrenia in children aged 9-12 years. Schizophr Res (2007) 1.44
Childhood onset schizophrenia: cortical brain abnormalities as young adults. J Child Psychol Psychiatry (2006) 1.43
Schizophrenia. N Engl J Med (1996) 1.42
Early detection and intervention in the initial prodromal phase of schizophrenia. Pharmacopsychiatry (2003) 1.40
Psychotic-like experiences in a community sample of adolescents: implications for the continuum model of psychosis and prediction of schizophrenia. Aust N Z J Psychiatry (2009) 1.31
Psychoeducation for schizophrenia. Cochrane Database Syst Rev (2011) 1.31
A 1-year double-blind study of 2 doses of long-acting risperidone in stable patients with schizophrenia or schizoaffective disorder. J Clin Psychiatry (2006) 1.31
Childhood-onset schizophrenia: A double-blind, randomized clozapine-olanzapine comparison. Arch Gen Psychiatry (2006) 1.30
Effects of race on psychiatric diagnosis of hospitalized adolescents: a retrospective chart review. J Child Adolesc Psychopharmacol (2001) 1.17
Olanzapine versus placebo in adolescents with schizophrenia: a 6-week, randomized, double-blind, placebo-controlled trial. J Am Acad Child Adolesc Psychiatry (2009) 1.15
Practice parameter for the assessment and treatment of children and adolescents with schizophrenia. American Academy of Child and Adolescent Psychiatry. J Am Acad Child Adolesc Psychiatry (2001) 1.13
A 6-week, randomized, double-blind, placebo-controlled study of the efficacy and safety of risperidone in adolescents with schizophrenia. J Child Adolesc Psychopharmacol (2009) 1.12
Recognizing and monitoring adverse events of second-generation antipsychotics in children and adolescents. Child Adolesc Psychiatr Clin N Am (2006) 1.10
Treatment of early-onset schizophrenia spectrum disorders (TEOSS): rationale, design, and methods. J Am Acad Child Adolesc Psychiatry (2007) 1.09
Thought disorder and communication deviance as predictors of outcome in youth at clinical high risk for psychosis. J Am Acad Child Adolesc Psychiatry (2011) 1.07
Patients in the early phases of schizophrenia and schizoaffective disorders effectively treated with risperidone long-acting injectable. J Psychopharmacol (2005) 1.07
Why do patients with psychosis use cannabis and are they ready to change their use? Int J Dev Neurosci (2010) 1.06
Obstetric conditions and risk of first admission with schizophrenia: a Danish national register based study. Schizophr Res (2007) 1.05
Altered transcript expression of NMDA receptor-associated postsynaptic proteins in the thalamus of subjects with schizophrenia. Am J Psychiatry (2003) 1.01
Minimal injection site pain and high patient satisfaction during treatment with long-acting risperidone. Int Clin Psychopharmacol (2005) 1.01
Premorbid characterization in schizophrenia: the Pittsburgh High Risk Study. World Psychiatry (2004) 1.01
Pharmacological intervention in the initial prodromal phase of psychosis. Eur Psychiatry (2005) 0.99
Elevated prolactin levels in male youths treated with risperidone and quetiapine. J Child Adolesc Psychopharmacol (2005) 0.98
Childhood onset schizophrenia: support for a progressive neurodevelopmental disorder. Int J Dev Neurosci (2010) 0.98
Prevalence and correlates of auditory vocal hallucinations in middle childhood. Br J Psychiatry (2010) 0.98
A randomized, double-blind study of paliperidone extended-release in treatment of acute schizophrenia in adolescents. Biol Psychiatry (2011) 0.95
Adjunctive use of lithium carbonate for the management of neutropenia in clozapine-treated children. Hum Psychopharmacol (2009) 0.95
One-year incidence rates of tardive dyskinesia in children and adolescents treated with second-generation antipsychotics: a systematic review. J Child Adolesc Psychopharmacol (2007) 0.93
Efficacy and safety of quetiapine in adolescents with schizophrenia investigated in a 6-week, double-blind, placebo-controlled trial. J Child Adolesc Psychopharmacol (2012) 0.93
Childhood-onset schizophrenia: premorbid and prodromal diagnostic and treatment histories. J Am Acad Child Adolesc Psychiatry (2002) 0.93
Is autism spectrum disorder common in schizophrenia? Psychiatry Res (2012) 0.93
Long-acting injectable antipsychotics in early psychosis: a literature review. Early Interv Psychiatry (2013) 0.93
Structural brain MRI abnormalities in healthy siblings of patients with childhood-onset schizophrenia. Am J Psychiatry (2003) 0.92
Cognitive behaviour therapy for schizophrenia. Cochrane Database Syst Rev (2004) 0.92
Treatment of adolescents with early-onset schizophrenia spectrum disorders: in search of a rational, evidence-informed approach. Curr Opin Psychiatry (2013) 0.90
Abnormal neurologic maturation in adolescents with early-onset schizophrenia. Am J Psychiatry (2001) 0.88
The schizophrenia prodrome: a developmentally informed review and update for psychopharmacologic treatment. Child Adolesc Psychiatr Clin N Am (2006) 0.84
Abnormal infant neurodevelopment predicts schizophrenia spectrum disorders. J Child Adolesc Psychopharmacol (2005) 0.84
Psychotic symptoms in pediatric bipolar disorder. J Affect Disord (2004) 0.84
Ictal asystole and anti-N-methyl-D-aspartate receptor antibody encephalitis. Pediatrics (2011) 0.81
Case study: trauma-related hallucinations. J Am Acad Child Adolesc Psychiatry (1997) 0.79
Smooth pursuit eye-tracking impairment in childhood-onset psychotic disorders. Am J Psychiatry (2001) 0.79
Initial medical work-up of first-episode psychosis: a conceptual review. Early Interv Psychiatry (2009) 0.79
An open trial of clozapine in 11 adolescents with childhood-onset schizophrenia. J Am Acad Child Adolesc Psychiatry (1994) 0.79
Cannabis use disorder and age at onset of psychosis--a study in first-episode patients. Schizophr Res (2011) 0.78
Schizophrenia with onset before the age of eleven: clinical characteristics of onset and course. J Autism Dev Disord (2000) 0.78
Anti-NMDAR encephalitis: a new, severe and challenging enduring entity. Eur Child Adolesc Psychiatry (2012) 0.77
A New Psychosocial Tool for Gaining Patient Understanding and Acceptance of Long-acting Injectable Antipsychotic Therapy. Psychiatry (Edgmont) (2009) 0.77
Empirical evidence for psychopharmacologic treatment in early-onset psychosis and schizophrenia. Child Adolesc Psychiatr Clin N Am (2012) 0.77
EEG abnormalities and two year outcome in first episode psychosis. Acta Psychiatr Scand (2005) 0.76
Neuroimaging schizophrenia: a picture is worth a thousand words, but is it saying anything important? Curr Psychiatry Rep (2013) 0.76
Benztropine prophylaxis of dystonic reactions. Psychopharmacology (Berl) (1979) 0.76
Schooling students with psychotic disorders. Child Adolesc Psychiatr Clin N Am (2012) 0.75
Cognitive impairment associated with atrial fibrillation: a meta-analysis. Ann Intern Med (2013) 3.76
Stimulants and sudden death: what is a physician to do? Pediatrics (2006) 1.64
The diagnosis and treatment of Munchausen's syndrome. Gen Hosp Psychiatry (2003) 1.51
The use of benzodiazepines in the treatment of chest pain: a review of the literature. J Emerg Med (2003) 1.41
Core competencies for fellowship training in psychosomatic medicine: a collaborative effort by the APA Council on Psychosomatic Medicine, the ABPN Psychosomatic Committee, and the Academy of Psychosomatic Medicine. Psychosomatics (2009) 1.39
Central pontine myelinolysis manifested by temporary blindness: a possible complication of lithium toxicity. Ann Clin Psychiatry (2002) 1.38
Administration of olanzapine to prevent postoperative delirium in elderly joint-replacement patients: a randomized, controlled trial. Psychosomatics (2010) 1.33
The impact of serious mental illness on health and healthcare. Psychosomatics (2010) 1.28
Visual hallucinations: differential diagnosis and treatment. Prim Care Companion J Clin Psychiatry (2009) 1.20
Insertion of foreign bodies (polyembolokoilamania): underpinnings and management strategies. Prim Care Companion CNS Disord (2012) 1.19
Falls in the general hospital: association with delirium, advanced age, and specific surgical procedures. Psychosomatics (2009) 1.04
Dread complications of catatonia: a case discussion and review of the literature. Prim Care Companion J Clin Psychiatry (2008) 1.03
Conversion disorder presenting with neurologic and respiratory symptoms. Prim Care Companion J Clin Psychiatry (2005) 1.00
Linezolid and serotonin syndrome. Prim Care Companion J Clin Psychiatry (2009) 1.00
Improving access to mental health care for children: the Massachusetts Child Psychiatry Access Project. Pediatrics (2010) 1.00
Neuropsychiatric effects of prescription drug abuse. Neuropsychol Rev (2007) 0.99
Linking electronic health record-extracted psychosocial data in real-time to risk of readmission for heart failure. Psychosomatics (2011) 0.99
The neuropsychiatric complications of glucocorticoid use: steroid psychosis revisited. Psychosomatics (2012) 0.95
Neuropsychiatric consequences of cardiovascular medications. Dialogues Clin Neurosci (2007) 0.92
Successful implementation of an alcohol-withdrawal pathway in a general hospital. Psychosomatics (2008) 0.90
Comorbid pain, depression, and anxiety: multifaceted pathology allows for multifaceted treatment. Harv Rev Psychiatry (2009) 0.90
Prior discharges against medical advice and withdrawal of consent: what they can teach us about patient management. Prim Care Companion CNS Disord (2011) 0.90
Depressogenic effects of medications: a review. Dialogues Clin Neurosci (2011) 0.89
The effect of testosterone levels on mood in men: a review. Psychosomatics (2013) 0.88
An open trial of bupropion for the treatment of adults with attention-deficit/hyperactivity disorder and bipolar disorder. Biol Psychiatry (2003) 0.88
Methadone-Associated QTc Prolongation: A Case Report and Review of the Literature. Prim Care Companion J Clin Psychiatry (2008) 0.88
Psychiatric considerations in the patient receiving organ transplantation: a clinical case conference. Gen Hosp Psychiatry (2004) 0.88
Documentation of decision-making capacity, informed consent, and health care proxies: a study of surrogate consent. Psychosomatics (2011) 0.87
Alcohol use during pregnancy: prevalence and impact. Prim Care Companion J Clin Psychiatry (2007) 0.86
Insulin overdose among patients with diabetes: a readily available means of suicide. Prim Care Companion J Clin Psychiatry (2009) 0.86
Bupropion SR for the treatment of substance-abusing outpatient adolescents with attention-deficit/hyperactivity disorder and mood disorders. J Child Adolesc Psychopharmacol (2005) 0.85
Neuropsychiatric manifestations of multiple sclerosis. Prim Care Companion J Clin Psychiatry (2008) 0.85
The use of DBT skills in the treatment of difficult patients in the General Hospital. Psychosomatics (2003) 0.84
Staying against advice: refusal to leave the hospital. Prim Care Companion J Clin Psychiatry (2010) 0.83
Complications of carbon monoxide poisoning: a case discussion and review of the literature. Prim Care Companion J Clin Psychiatry (2009) 0.83
Denial of cardiac illness: consequences and management. Prim Care Companion CNS Disord (2011) 0.83
Consultants' conflicts: a case discussion of differences and their resolution. Psychosomatics (2008) 0.83
Aripiprazole-related tardive dyskinesia. CNS Spectr (2006) 0.83
Treatment of ADHD with stimulant medications: response to Nissen perspective in the New England Journal of Medicine. J Am Acad Child Adolesc Psychiatry (2006) 0.82
Demoralization in medical practice. Prim Care Companion J Clin Psychiatry (2007) 0.82
Medical complications of psychiatric treatment. Crit Care Clin (2008) 0.81
Clinical experience with the management of schizophrenia in the general hospital. Psychosomatics (2003) 0.81
"Playing possum:" differential diagnosis, work-up, and treatment of profound interpersonal withdrawal. Psychosomatics (2011) 0.81
Plasma methylphenidate concentrations in youths treated with high-dose osmotic release oral system formulation. J Child Adolesc Psychopharmacol (2010) 0.81
Psychotic symptoms in the elderly. Prim Care Companion J Clin Psychiatry (2005) 0.81
Teaching residents about emotional intelligence and its impact on leadership. Acad Psychiatry (2014) 0.81
Reactions to amputation: recognition and treatment. Prim Care Companion J Clin Psychiatry (2007) 0.80
Clinical Challenges to the Delivery of End-of-Life Care. Prim Care Companion J Clin Psychiatry (2006) 0.80
Cocaine and opioid use during pregnancy: prevalence and management. Prim Care Companion J Clin Psychiatry (2008) 0.79
Individual risk profiles for postoperative delirium after joint replacement surgery. Psychosomatics (2011) 0.79
Acute psychiatric manifestations of stroke: a clinical case conference. Psychosomatics (2003) 0.79
Adolescent substance use disorders in the school setting. Child Adolesc Psychiatr Clin N Am (2012) 0.79
Current approaches to the recognition and treatment of alcohol withdrawal and delirium tremens: "old wine in new bottles" or "new wine in old bottles". Prim Care Companion J Clin Psychiatry (2010) 0.79
Processing acute traumatic grief: exacerbation of posttraumatic stress disorder after September 11 in a 9-year-old boy. Harv Rev Psychiatry (2002) 0.79
Use of complementary and alternative medicine by patients with cancer. Prim Care Companion CNS Disord (2011) 0.79
The impact of body image on patient care. Prim Care Companion J Clin Psychiatry (2010) 0.78
Is depression an appropriate response to having cancer? A discussion of diagnostic criteria and treatment decisions. Prim Care Companion J Clin Psychiatry (2007) 0.78
Caring for homeless persons with serious mental illness in general hospitals. Psychosomatics (2013) 0.77
An Open Trial of Sustained Release Bupropion for Attention-Deficit/Hyperactivity Disorder in Adults with ADHD plus Substance Use Disorders. J ADHD Relat Disord (2010) 0.77
Diagnosis and management of depression in 3 countries: results from a clinical vignette factorial experiment. Prim Care Companion CNS Disord (2011) 0.77
The assessment and management of agitation and delirium in the general hospital. Prim Care Companion J Clin Psychiatry (2010) 0.77
Intoxications associated with agitation, tachycardia, hypertension, and Fever: differential diagnosis, evaluation, and management. Prim Care Companion CNS Disord (2013) 0.77
Phenytoin toxicity secondary to an oxcarbazepine-phenytoin 2C19 interaction. Psychosomatics (2010) 0.77
Cognitive and perceptual disturbances in a young man. Prim Care Companion J Clin Psychiatry (2007) 0.77
A complex presentation of complex partial seizures. Prim Care Companion J Clin Psychiatry (2006) 0.77
Obesity: its epidemiology, comorbidities, and management. Prim Care Companion CNS Disord (2013) 0.77
Using Psychostimulants to Treat Depression in the Medically Ill. Prim Care Companion J Clin Psychiatry (2004) 0.76
Lost in the black box: juvenile depression, suicide, and the FDA's black box. J Pediatr (2005) 0.76
Delirium-associated disulfiram and ethanol interactions. Prim Care Companion J Clin Psychiatry (2005) 0.76
Using stimulants for attention-deficit/hyperactivity disorder: clinical approaches and challenges. Prim Care Companion CNS Disord (2013) 0.76
Toxicologic testing for opiates: understanding false-positive and false-negative test results. Prim Care Companion CNS Disord (2012) 0.75
Fear of medical illness: differential diagnosis, workup, and treatment. Prim Care Companion J Clin Psychiatry (2008) 0.75
Involuntary hospitalization of primary care patients. Prim Care Companion CNS Disord (2014) 0.75
Recognition of psychiatric symptoms and conditions in latino patients. Prim Care Companion CNS Disord (2011) 0.75
Evaluation and Treatment of the Angry Patient. Prim Care Companion CNS Disord (2016) 0.75
Late-onset cinephilia and compulsive behaviors: harbingers of frontotemporal dementia. Prim Care Companion CNS Disord (2011) 0.75
Selecting neuroimaging techniques: a review for the clinician. Prim Care Companion CNS Disord (2013) 0.75
Schooling students with psychotic disorders. Child Adolesc Psychiatr Clin N Am (2012) 0.75
Multiple neurologic, psychiatric, and endocrine complaints in a young woman: a case discussion and review of the clinical features and management of mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke. Prim Care Companion J Clin Psychiatry (2008) 0.75
The recognition and management of psychological reactions to stroke: a case discussion. Prim Care Companion J Clin Psychiatry (2006) 0.75
Collaboration and Referral Between Internal Medicine and Psychiatry. Prim Care Companion CNS Disord (2015) 0.75
Obstacles to the Prescription and Use of Opioids. Prim Care Companion CNS Disord (2016) 0.75
Sadness: diagnosis, evaluation, and treatment. Prim Care Companion CNS Disord (2014) 0.75
Found in feces: differential diagnosis, workup, and treatment. Prim Care Companion CNS Disord (2012) 0.75
The desire for death in the setting of terminal illness: a case discussion. Prim Care Companion J Clin Psychiatry (2006) 0.75
Alcohol withdrawal in the setting of elevated blood alcohol levels. Prim Care Companion J Clin Psychiatry (2006) 0.75
Fainting, swooning, and syncope. Prim Care Companion CNS Disord (2011) 0.75
Narcissistic Patients: Understanding and Managing Feelings and Behaviors. Prim Care Companion CNS Disord (2015) 0.75
Helplessness in the helpers: etiology and management. Prim Care Companion CNS Disord (2013) 0.75
The cognitive impact of atrial fibrillation. Prim Care Companion CNS Disord (2013) 0.75
Regression: Diagnosis, Evaluation, and Management. Prim Care Companion CNS Disord (2015) 0.75
Lies in the doctor-patient relationship. Prim Care Companion J Clin Psychiatry (2009) 0.75
Impact of the Doctor-Patient Relationship. Prim Care Companion CNS Disord (2015) 0.75
The management of alcohol use disorders: the impact of pharmacologic, affective, behavioral, and cognitive approaches. Prim Care Companion CNS Disord (2014) 0.75
Neuropsychiatric phenomena associated with movement disorders. Prim Care Companion J Clin Psychiatry (2006) 0.75
Liability associated with prescribing medications. Prim Care Companion J Clin Psychiatry (2009) 0.75
Evaluation and treatment of poor sleep. Prim Care Companion J Clin Psychiatry (2007) 0.75